![bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma CAS 5072 PDF] Targeting Glutathione Metabolism: Partner](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fbcj.2014.45/MediaObjects/41408_2014_Article_BFbcj201445_Fig6_HTML.jpg)
bso glutathione inhibitor
bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma CAS 5072 PDF] Targeting Glutathione Metabolism: Partner
PDF] Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy Semantic Scholar A novel small molecule that induces cytotoxicity in lung cancer cells inhibits disulfide reductases GSR and TXNRD1 bioRxiv Differentiating Changes in Glutathione Levels from Cytotoxic Events Using Multiplexed Assays Depletion of cellular GSH by treatment with l Download Scientific Diagram Frontiers Systemic L Buthionine S R Sulfoximine Treatment Increases Plasma NGF and Upregulates L cys L cys2 Transporter and Glutamylcysteine Ligase mRNAs Through the NGF TrkA Akt Nrf2 Pathway in the Striatum
USD27.58
USD52.58
Pay in 4 interest-free payments of $6.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
![bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma CAS 5072 PDF] Targeting Glutathione Metabolism: Partner](https://ai2-s2-public.s3.amazonaws.com/figures/2017-08-08/5fac76d6ebe16906329204d929b1af00b50c2fd3/3-Figure1-1.png)
![bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma CAS 5072 PDF] Targeting Glutathione Metabolism: Partner](https://www.biorxiv.org/content/biorxiv/early/2021/06/28/2021.06.28.450088/F5.large.jpg)
![bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma CAS 5072 PDF] Targeting Glutathione Metabolism: Partner](https://worldwide.promega.com/-/media/images/resources/figures/11900-11999/11972ma_596px.jpg?rev=d003e8cfa5c64255a4efb41d07127318&sc_lang=en)
![bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma CAS 5072 PDF] Targeting Glutathione Metabolism: Partner](https://www.researchgate.net/publication/233801680/figure/fig1/AS:299977294270464@1448531568238/Depletion-of-cellular-GSH-by-treatment-with-l-buthionine-S-R-sulfoximine-BSO-induces.png)
![bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma CAS 5072 PDF] Targeting Glutathione Metabolism: Partner](https://www.frontiersin.org/files/Articles/472573/xml-images/fncel-13-00325-g001.webp)